Skip to content

A multicenter randomized controlled study of invasive blood pressure monitoring via the distal radial artery versus the radial artery access

A multicenter randomized controlled study of invasive blood pressure monitoring via the distal radial artery versus the radial artery access

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101331
Enrollment
Unknown
Registered
2025-04-23
Start date
2025-01-17
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Heart Disease

Interventions

Research group:Perform invasive blood pressure monitoring via the distal radial artery approach
Control group:Perform invasive blood pressure monitoring via the Tradiional radial artery approach

Sponsors

The General Hospital of the Eighth Division, Shihezi City (Shihezi People's Hospital, the Third Affiliated Hospital of Shihezi University Medical College)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) A critically ill patient who need invasive blood pressure monitoring while being conscious after clinical assessment; (2) Before the operation, palpation of the distal and proximal radial arteries and the presence of radial artery pulsation were performed; (3) The patient agreed to participate the study.

Exclusion criteria

Exclusion criteria: (1) Ultrasound confirmed that the radial artery or the distal segment was occluded (no blood flow in the radial artery ); (2) Communication disorder; (3) Positive modified Allen test

Design outcomes

Primary

MeasureTime frame
The success rate of the first catheterization;

Secondary

MeasureTime frame
(1) The incidence of major adverse cardiovascular and cerebrovascular events (all-cause death, cardiovascular death, new-onset myocardial infarction, new-onset stroke); (2) The occlusion rate of TRA and dTRA 24 hours after extubation; (3) Local complications (hematoma, neurological complications); (4) BARC-defined major bleeding (types 2, 3 and 5); (5) Crossing of the surgical approach; (6) Pain and daily living ability scores; (7) Whether the tube was removed.;

Countries

China

Contacts

Public ContactLiu Hongmei

The General Hospital of the Eighth Division, Shihezi City (Shihezi People's Hospital, the Third Affiliated Hospital of Shihezi University Medical College)

1545907523@qq.com+86 151 9957 8869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 22, 2026